GWG Holdings ROA 2024

Ką veikia GWG Holdings?

GWG Holdings Inc is one of the leading companies in the life insurance secondary market. It was founded in 2006 by Jon Sabes and Paul Siegert. The company is headquartered in Minneapolis, Minnesota and is listed on the NASDAQ stock exchange under the ticker symbol GWGH. The company's business model is based on purchasing life insurance policies from individuals and companies who no longer need them or can no longer afford them. GWG Holdings Inc acquires these policies at a price lower than the expected payout amount. This creates a win-win situation as policyholders benefit from immediately available funds, while GWG Holdings Inc profitably conducts the insurance and policy trading business. The company is divided into several divisions and offers various products and services. In the traditional life insurance provider division, several product options are offered. These include life insurance policy surrender agreements that allow heirs of deceased individuals to purchase insurance policies from them. This also includes "life insurance premium payments," where the policyholder pays a sum to the insurer and obtains their insurance policy. GWG Holdings Inc also offers services such as the LifeCare Xchange program, which helps individuals and companies transfer policies from one life insurance provider to another or benefit from a cash payment. Through the acquisition of Epigenomics AG, the company is also involved in cancer diagnostics. Epigenomics AG is a leading provider of in-vitro diagnostics (IVD) for cancer detection. The company's technology allows for the detection of tumor markers in blood samples and is approved in the US (but not in the EU) due to EU legislation stating that blood tests for cancer can only be conducted in hospitals, which Epigenomics AG is unable to fulfill. Overall, GWG Holdings Inc has an impressive success story based on innovative business models and a clever acquisition strategy. The company has become a key player in the life insurance secondary market industry and offers customers a variety of options and services. Through the acquisition of Epigenomics AG, the company has also entered the field of cancer diagnostics, expanding its portfolio. GWG Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.